Department of Pediatrics, Siriraj hospital, Mahidol University
Bangkok, 10700, Thailand
NCT Number: NCT01156038
Atopy patch test in normal population
Looking for future studies?
Notify Me18 year–40 year
All sexes
Interventional
Phase 1
Bangkok, 10700, Thailand
The initial diagnostic work up of suspected food allergy includes patient's history, skin prick test (SPT), measurement of food specific immunoglobulin E (IgE) with serological assays, and more recently the atopy patch test. A positive SPT seems to reflect early reactions to food challenges, whereas the atopy patch test has a high diagnostic efficacy for late phase clinical reactions. The purpose of this study was to evaluate atopy patch test reaction in non-atopic population.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Atopy patches used with food lyophilized allergen and commercial allergen were placed on back of subjects for 48 hrs then atopy patches were taken off. Subjects should return to evaluate reaction one day later(72 hrs after applying atopy patch test)
Time frame: 3 days
To evaluate outcome of atopy patch test reaction in non-atopic subject
Time frame: 3 days
To compare outcome of atopy patch test reaction using lyophilized allergen and commercial allergen
Mahidol University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07308028
Normal
Ta'if, Saudi Arabia
View Trial DetailsNCT00594217
Normal, PCOS
Charlottesville, Virginia, United States
View Trial DetailsNCT06250868
Normal
La Jolla, California, United States
View Trial DetailsNCT05532410
Eye Diseases, Glaucoma
Chicago, Illinois, United States
View Trial Details